Steven Cohen Global Blood Therapeutics, Inc. Call Options Transaction History

Point72 Asset Management, L.P.

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 16, 2021	BUY	$32.46 - $43.42 $24.3 Million - $32.6 Million	750,000 Added 300.0%	1,000,000 $35 Million
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $11.4 Million - $20.5 Million	250,000 New	250,000 $19.9 Million
Q3 2018 Nov 14, 2018	SELL	$38.0 - $51.1 $27.6 Million - $37.1 Million	-726,700 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $18.4 Million - $23.9 Million	476,700 Added 190.68%	726,700 $32.8 Million
Q1 2018 May 15, 2018	BUY	$39.6 - $65.9 $1.98 Million - $3.3 Million	50,000 Added 25.0%	250,000 $12.1 Million
Q4 2017 Feb 14, 2018	BUY	$29.7 - $45.7 $5.94 Million - $9.14 Million	200,000	200,000 $7.87 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.